Allelica is a global life sciences company powering the healthcare and pharmaceutical industries with comprehensive solutions for the development and commercialization of clinical genetic tests. Uniquely positioned as innovators in genetic risk prediction and experts in medical devices, Allelica offers a cutting-edge quality management system, specifically designed to develop and implement new genetics based assays.
With an agile quality management system (QMS) built uniquely for clinical genetic tests, Allelica provides healthcare providers, biotechs and pharmaceutical companies with expertise and world class software for the development and validation of new genetic tests, from conception to commercialization.
Allelica is the leading provider of ancestry-specific clinical polygenic risk score testing in the US and Europe.
Available as an on-premise or cloud-based solution, Allelica’s suite of digital tools enables laboratories to perform clinical PRS, Pharmacogenetics, and Carrier Screening analyses in-house. In addition to flexible software access options, Allelica offers multilingual, white label reporting for a range of our customizable PRS, PGx and CS panels.
"With this agreement, Merck confirms its strong commitment to advancing science and technology in the area of cardiovascular disease"
Our products are developed and validated using world class datasets and state-of-the-art technology to ensure the highest level of quality.
We are a group of international scientists and researchers committed to maintaining standards of academic excellence every step of the way.
Everything we do works towards our common goal of providing tangible improvement in preventive healthcare to help humans live a longer, healthier life.